IONS icon

Ionis Pharmaceuticals
IONS

Overview Fund Activity

307 hedge funds and large institutions have $4.93B invested in Ionis Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 111 increasing their positions, 94 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
307
Holders Change
-18
Holders Change %
-5.54%
% of All Funds
7.04%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
31
Increased
111
Reduced
94
Closed
48
Calls
$45.1M
Puts
$56.9M
Net Calls
-$11.7M
Net Calls Change
-$14.7M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$126M
2
BI
BVF Inc
California
+$23.8M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$23.3M
4
FLAM
First Light Asset Management
Minnesota
+$18.8M
5
PCM
Peregrine Capital Management
Minnesota
+$13.6M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$29.4M
2
Two Sigma Investments
Two Sigma Investments
New York
-$14.8M
3
BC
Boxer Capital
California
-$13.8M
4
Citadel Advisors
Citadel Advisors
Florida
-$12.3M
5
Goldman Sachs
Goldman Sachs
New York
-$12.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
AF
351
Allworth Financial
California
– -$1K -29 Closed
WOC
352
West Oak Capital
California
– -$1.15K -26 Closed
11 12 13 14
15